The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pao, L. I.
Right arrow Articles by Cambier, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pao, L. I.
Right arrow Articles by Cambier, J. C.
The Journal of Immunology, 1998, 160: 3305-3314.
Copyright © 1998 by The American Association of Immunologists

Asymmetrical Phosphorylation and Function of Immunoreceptor Tyrosine-Based Activation Motif Tyrosines in B Cell Antigen Receptor Signal Transduction

Lily I. Pao, Sara J. Famiglietti and John C. Cambier1

Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206

CD79a and CD79b function as transducers of B cell antigen receptor signals via a cytoplasmic sequence, termed the immunoreceptor tyrosine-based activation motif (ITAM). ITAMs contain two conserved tyrosines that may become phosphorylated upon receptor aggregation and bind distinct effectors by virtue of the distinct preference of phosphotyrosyl-containing sequences for SH2 domains. To explore the function of CD79a and CD79b ITAM tyrosines, we created membrane molecules composed of MHC class II I-Ak extracellular and transmembrane domains, and CD79a or CD79b cytoplasmic domains in which one or both of the ITAM tyrosines were mutated to phenylalanine. Functional analysis revealed that both ITAM tyrosines are required for ligand-induced Syk phosphorylation. However CD79a-ITAM and CD79b-ITAM tyrosine phosphorylations were asymmetrical, with >80% of phosphorylation occurring on the N-terminal tyrosine (Y-E-G-L). Thus, these findings suggest that following receptor ligation, only a minor proportion of phosphorylated ITAMs are doubly phosphorylated and thus can engage Syk. Only the N-terminal ITAM tyrosine of CD79a was required for ligand-mediated phosphorylation of the receptor and a subset of downstream substrates, including p62, p110, and Shc, and for Ca2+ mobilization. However, responses mediated through CD79b exhibited a greater dependence on the presence of both tyrosines. Neither tyrosine in CD79a or CD79b appeared absolutely essential for Src family kinase phosphorylation. These results indicate that phosphorylations of the tyrosines in CD79a and CD79b occur with very different stoichiometry, and the respective tyrosyl residues have distinct functions.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
G. L. J. Fuller, J. A. E. Williams, M. G. Tomlinson, J. A. Eble, S. L. Hanna, S. Pohlmann, K. Suzuki-Inoue, Y. Ozaki, S. P. Watson, and A. C. Pearce
The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent Signaling Cascade
J. Biol. Chem., April 27, 2007; 282(17): 12397 - 12409.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Braselmann, V. Taylor, H. Zhao, S. Wang, C. Sylvain, M. Baluom, K. Qu, E. Herlaar, A. Lau, C. Young, et al.
R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 998 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Gazumyan, A. Reichlin, and M. C. Nussenzweig
Ig{beta} tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
J. Exp. Med., July 10, 2006; 203(7): 1785 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Reichlin, A. Gazumyan, H. Nagaoka, K. H. Kirsch, M. Kraus, K. Rajewsky, and M. C. Nussenzweig
A B Cell Receptor with Two Ig{alpha} Cytoplasmic Domains Supports Development of Mature But Anergic B Cells
J. Exp. Med., March 15, 2004; 199(6): 855 - 865.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Marafioti, M. Pozzobon, M.-L. Hansmann, G. Delsol, S. A. Pileri, and D. Y. Mason
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease
Blood, January 1, 2004; 103(1): 188 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Faeder, W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein
Investigation of Early Events in Fc{epsilon}RI-Mediated Signaling Using a Detailed Mathematical Model
J. Immunol., April 1, 2003; 170(7): 3769 - 3781.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. B. Gauld, J. M. Dal Porto, and J. C. Cambier
B Cell Antigen Receptor Signaling: Roles in Cell Development and Disease
Science, May 31, 2002; 296(5573): 1641 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Kabak, B. J. Skaggs, M. R. Gold, M. Affolter, K. L. West, M. S. Foster, K. Siemasko, A. C. Chan, R. Aebersold, and M. R. Clark
The Direct Recruitment of BLNK to Immunoglobulin {alpha} Couples the B-Cell Antigen Receptor to Distal Signaling Pathways
Mol. Cell. Biol., April 15, 2002; 22(8): 2524 - 2535.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. J. Benschop, E. Brandl, A. C. Chan, and J. C. Cambier
Unique Signaling Properties of B Cell Antigen Receptor in Mature and Immature B Cells: Implications for Tolerance and Activation
J. Immunol., October 15, 2001; 167(8): 4172 - 4179.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Kraus, L. I. Pao, A. Reichlin, Y. Hu, B. Canono, J. C. Cambier, M. C. Nussenzweig, and K. Rajewsky
Interference with Immunoglobulin (Ig){alpha} Immunoreceptor Tyrosine-based Activation Motif (ITAM) Phosphorylation Modulates or Blocks B Cell Development, Depending on the Availability of an Ig{beta} Cytoplasmic Tail
J. Exp. Med., August 20, 2001; 194(4): 455 - 470.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Reichlin, Y. Hu, E. Meffre, H. Nagaoka, S. Gong, M. Kraus, K. Rajewsky, and M. C. Nussenzweig
B Cell Development Is Arrested at the Immature B Cell Stage in Mice Carrying a Mutation in the Cytoplasmic Domain of Immunoglobulin {beta}
J. Exp. Med., December 27, 2000; 193(1): 13 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
R. J. Benschop, D. Melamed, D. Nemazee, and J. C. Cambier
Distinct Signal Thresholds for the Unique Antigen Receptor–linked Gene Expression Programs in Mature and Immature B Cells
J. Exp. Med., September 20, 1999; 190(6): 749 - 756.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Tomasello, L. Olcese, F. Vely, C. Geourgeon, M. Blery, A. Moqrich, D. Gautheret, M. Djabali, M.-G. Mattei, and E. Vivier
Gene Structure, Expression Pattern, and Biological Activity of Mouse Killer Cell Activating Receptor-associated Protein (KARAP)/DAP-12
J. Biol. Chem., December 18, 1998; 273(51): 34115 - 34119.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. S. Gaul, M. L. Harrison, R. L. Geahlen, R. A. Burton, and C. B. Post
Substrate Recognition by the Lyn Protein-tyrosine Kinase. NMR STRUCTURE OF THE IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF SIGNALING REGION OF THE B CELL ANTIGEN RECEPTOR
J. Biol. Chem., May 19, 2000; 275(21): 16174 - 16182.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. S. Gordon, R. M. Kato, F. Lansigan, A. A. Thompson, R. Wall, and D. J. Rawlings
Aberrant B cell receptor signaling from B29 (Igbeta , CD79b) gene mutations of chronic lymphocytic leukemia B cells
PNAS, May 9, 2000; 97(10): 5504 - 5509.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.